DAVIDSON KEMPNER CAPITAL MANAGEMENT LP

Q3 2014 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Eric Sacks - Chief Financial Officer
Location
New York, New York
Holdings as of
September 30, 2014
Value $
$65 M
Num holdings
2
Date filed
2/13/2015, 02:19 PM
Description
Request for Confidential Treatment (11/14/2014): Confidential Treatment Expired on 11/16/2015
Previous filing
Q2 2014 - Aug 14, 2014
Next filing
Q4 2014 - Feb 13, 2015
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 11-14-2014 pursuant to a request for confidential treatment and for which confidential treatment expired on 11-16-2015.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Richard D. Chase Chief Financial Officer New York, New York 2/13/2015

Effective January 1, 2014, Davidson Kempner Capital Management LLC (?DKCM LLC?) and Davidson Kempner International Advisors, L.L.C. (?DKIA?) merged and became Davidson Kempner Capital Management LP (?DKCM LP?), which assumed all of the rights and obligations of DKCM LLC and DKIA, including duties as the SEC-registered investment adviser. As a result of the merger, a Form 13F will be filed for the surviving entity, DKCM LP, beginning for the quarter ending March 31, 2014. Form 13F will continue to be filed for DKCM LLC for 1Q14, 2Q14 and 3Q14 as required, but reflecting no 13F securities (since those 13F securities will be reported on DKCM LP's Form 13F beginning March 31, 2014).